201 related articles for article (PubMed ID: 17380078)
1. Expression of G1 cell cycle regulators in rat liver upon repeated exposure to thioacetamide.
Kim KT; Han SY; Jeong JS
Korean J Hepatol; 2007 Mar; 13(1):81-90. PubMed ID: 17380078
[TBL] [Abstract][Full Text] [Related]
2. Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.
Funakoshi F; Masaki T; Kita Y; Hitomi M; Kurokohchi K; Uchida N; Watanabe S; Yoshiji H; Kuriyama S
Int J Mol Med; 2004 Jun; 13(6):779-87. PubMed ID: 15138612
[TBL] [Abstract][Full Text] [Related]
3. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
4. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
Devi SS; Mehendale HM
Toxicol Appl Pharmacol; 2005 Sep; 207(2):89-102. PubMed ID: 15953624
[TBL] [Abstract][Full Text] [Related]
5. Changes in expression of cell cycle regulators after G1 progression upon repetitive thioacetamide treatment in rat liver.
Hong SH; Lee GD; Chung JY; Cho KS; Park SH; Kim IH; Jeong JS
Exp Mol Med; 2002 Nov; 34(5):361-6. PubMed ID: 12526100
[TBL] [Abstract][Full Text] [Related]
6. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
7. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
Gonzales AJ; Goldsworthy TL; Fox TR
Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
[TBL] [Abstract][Full Text] [Related]
9. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
Ruas M; Gregory F; Jones R; Poolman R; Starborg M; Rowe J; Brookes S; Peters G
Mol Cell Biol; 2007 Jun; 27(12):4273-82. PubMed ID: 17420273
[TBL] [Abstract][Full Text] [Related]
10. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats.
Sawant SP; Dnyanmote AV; Mehendale HM
Toxicology; 2007 Apr; 232(3):200-15. PubMed ID: 17298859
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
17. Expression of positive and negative regulators of cell cycle during wound healing.
Zhu X; Di Y; Hu C; Wang Z
Chin Med J (Engl); 2002 Mar; 115(3):326-30. PubMed ID: 11940356
[TBL] [Abstract][Full Text] [Related]
18. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human prothrombin kringle-2 induces bovine capillary endothelial cell cycle arrest at G0-G1 phase through inhibition of cyclin D1/CDK4 complex: modulation of reactive oxygen species generation and up-regulation of cyclin-dependent kinase inhibitors.
Kim TH; Oh S; Kim SS
Angiogenesis; 2005; 8(4):307-14. PubMed ID: 16400524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
